You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 10, October 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Case Reports and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (36)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Anti-inflammatory and Healing Properties of Nerve Growth Factor in Immune Corneal Ulcers With Stromal Melting

Arch Ophthalmol. 2000;118:1446-1449.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Immune corneal ulcers are rare ocular surface diseases with multiple etiologies.1 Immunosuppressive drugs and systemic or topical steroids may occasionally control the inflammatory process, but in the more severe cases, the ulcer may progress to corneal melting and perforation. No suitable therapy is currently available for these patients.1 In a recent uncontrolled study, topically applied exogenous nerve growth factor (NGF) restored corneal integrity in patients with corneal neurotrophic ulcers.2 Nerve growth factor might promote corneal healing and is implicated in functional activity of inflammatory cells on the ocular surface.3-5

We evaluated the efficacy of topical murine NGF6 treatment in 4 patients (Table 1) with severe corneal melting as a consequence of immune-related corneal peripheral ulcers. The patients received 1 drop of NGF solution (10 µg of NGF dissolved in 50 µL of saline solution, 0.9% of sodium chloride) in the conjunctival fornix every 2 hours (from 6 AM . . . [Full Text of this Article]

Report of Cases

Case 1

Case 2

Case 3

Case 4


Comment
Corresponding author: Luigi Aloe, PhD, Institute of Neurobiology, National Research Council, Viale Marx 15/43, 00137 Rome, Italy (e-mail: aloe@in.rm.cnr.it).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular basis for keratoconus: Lack of TrkA expression and its transcriptional repression by Sp3
Lambiase et al.
Proc. Natl. Acad. Sci. USA 2005;102:16795-16800.
ABSTRACT | FULL TEXT  

Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production
Bracci-Laudiero et al.
Blood 2005;106:3507-3514.
ABSTRACT | FULL TEXT  

Neurotrophin Overexpression in Lower Airways of Infants with Respiratory Syncytial Virus Infection
Tortorolo et al.
Am. J. Respir. Crit. Care Med. 2005;172:233-237.
ABSTRACT | FULL TEXT  

Improving ischaemic skin revascularisation by nerve growth factor in a child with crush syndrome
Chiaretti et al.
Arch. Dis. Child. 2002;87:446-448.
ABSTRACT | FULL TEXT  

Intraocular Production and Release of Nerve Growth Factor after Iridectomy
Lambiase et al.
IOVS 2002;43:2334-2340.
ABSTRACT | FULL TEXT  

Role of cholecystokinin-8 in nerve growth factor and nerve growth factor mRNA expression in carrageenan-induced joint inflammation in adult rats
Manni et al.
Rheumatology (Oxford) 2002;41:787-792.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.